SCHEMBL3559889

SCHEMBL3559889

CC(=O)n1c(C)c(O)c2cc(Cl)ccc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 2/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ACLY P53396 2/20 0.42
POLB P06746 1/20 0.41
PTGS2 P35354 3/20 0.40
PTGS1 P23219 1/20 0.40
TSHR P16473 2/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
HSD17B10 Q99714 1/20 0.40
BAZ2B Q9UIF8 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.39
GABRA1 P14867 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3556523 0.87 GAA (0.44) GFERALDH1A1KDM4EMAPTNPC1
SCHEMBL27636576 0.83 ALDH1A1 (0.47) GFERALDH1A1KDM4EMAPTACLY
SCHEMBL3555128 0.81 BAZ2B (0.49) ALDH1A1POLBBAZ2B
SCHEMBL3556800 0.81 AKR1C3 (0.42) POLBPTGDR2
SCHEMBL3558589 0.78 MAPT (0.51) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL3558473 0.78 ACLY (0.47) KDM4EMAPTNPC1RAB9AKMT2A
SCHEMBL3557610 0.76 POLB (0.66) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL2479366 0.75 POLB (0.70) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL3553237 0.73 KDM4E (0.44) GFERALDH1A1KDM4EKMT2ATDP1
SCHEMBL17221651 0.73 RAB9A (0.44) GFERRAB9AACLYPOLBPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed
WO-2004048331-A1 N-ARYLALKYL-3-AMINOALKOXYINDOLES AND THEIR USE AS 5-HT LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT GFER 1772/4885ALDH1A1 1943/4885KDM4E 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.